Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.81K Buy
177
+1
+0.6% +$15 ﹤0.01% 312
2026
Q1
$2.38K Buy
176
+1
+0.6% +$14 ﹤0.01% 305
2025
Q4
$2.18K Hold
175
﹤0.01% 308
2025
Q3
$1.73K Buy
175
+1
+0.6% +$10 ﹤0.01% 309
2025
Q2
$1.55K Sell
174
-47
-21% -$397 ﹤0.01% 309
2025
Q1
$1.92K Buy
221
+1
+0.5% +$10 ﹤0.01% 294
2024
Q4
$2.74K Buy
+220
New +$2.7K ﹤0.01% 260

Other funds holding VTRS

Graney & King's VTRS Position: Q2 2026 in Review

Graney & King increased its Viatris (VTRS) stake by 0.57% in Q2 2026, buying an estimated $15 and bringing the position to 177 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Graney & King first reported a position in VTRS in Q4 2024 and has held it in 7 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Graney & King held 177 shares of Viatris worth $2.81K as of Q2 2026.
  • Graney & King bought 1 Viatris share in Q2 2026, an estimated $15.
  • Viatris made up ﹤0.01% of Graney & King's portfolio in Q2 2026, its #312 holding.
  • Graney & King first reported a position in Viatris in Q4 2024 and has held it in 7 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.